Services

13 - 24 of 249 listings
Listings
  • B9

    B9

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cells are a subclone derived from B13.29 (first described as clone 9.9) by fusion of BALB/c spleen cells with SP2/0-AG14 myeloma cells; this hybridoma is a non-producer. B9 is a mouse B cell hybridoma line that requires Interleukin 6 (IL-6) for survi...

  • SPC-BM-36

    SPC-BM-36

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Derived from larvae of a silkworm (species Bombyx mori, family Bombycidae, order Lepidoptera) (Seidenspinner) https://www.creative-bioarray.com/SPC-BM-36-CSC-C6198X-item-1678.htm

  • L929/A

    L929/A

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    This Adriamycin-resistant cell line has been developed by exposure of the parent L929 murine fibroblast cell line to increasing concentrations of doxorubicin in-vitro. L929/A cells can be used in the development of novel anti-cancer treatments. Resis...

  • LLC

    LLC

    Immunology Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-C6592J Description Highly metastatic and drug-resistant mouse tumor. Application consideration Species Mus musculus (Mouse) Source Lung https://www.creative-bioarray.com/llc-item-csc-c6592j-43466.htm

  • Mouse Hepatocytes

    Mouse Hepatocytes

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Our mouse hepatocytes are prepared using the same careful isolation and cryopreservation techniques as our human lots. Characterization methods of cryopreserved hepatocytes include ECOD, 7-HCG and 7-HCS for phase I and phase II enzyme activities. We ...

  • MC-38

    MC-38

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-6983J Description Established from C57BL/6 mouse colon adenocarcinoma Species Mus musculus (Mouse) Source Intestine; Colon Recommended Medium 90% RPMI-1640 + 10% h.i. FBS https://www.creative-bioarray.com/mc-38-csc-6983j-item-45531.htm

  • CT-26

    CT-26

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-C9367L Description Species Mus musculus (Mouse) Source Intestine; Colon Recommended Medium 90% RPMI-1640 + 10% h.i. FBS https://www.creative-bioarray.com/CT-26-CSC-C9367L-item-39544.htm

  • HCA-7 Colony 26

    HCA-7 Colony 26

    Immunology Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-C9466J Description Subpopulation isolated from the HCA-7 cell line Species Homo sapiens (Human) Source Intestine; Colon https://www.creative-bioarray.com/HCA-7-Colony-26-CSC-C9466J-item-42404.htm

  • FL83B

    FL83B

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    FL83B is a spontaneously immortalized hepatocyte cell line derived from the liver of a 15 to 17-day-old fetal C57BL/6J mouse. https://www.creative-bioarray.com/fl83b-csc-c7104j-item-49147.htm

  • NH-6

    NH-6

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-C6326J Description Human cell line derived from neuroblastoma of adrenal gland. Species Homo sapiens (Human) Source Adrenal Gland https://www.creative-bioarray.com/nh-6-item-csc-c6326j-42926.htm

  • BALB/3T3 clone A31

    BALB/3T3 clone A31

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Species: mouse - embryo, 14 to 17 days old, Mus musculus Strain: BALB/c Virus Susceptibility: Herpes simples; vesicular stomatitis (Indiana) Tumorigenecity: no https://www.creative-bioarray.com/BALB-3T3-clone-A31-CSC-C9339L-item-39487.htm

  • Py230

    Py230

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    The Py230 cell line is an epithelial-like murine mammary luminal tumor cell line that has properties similar to those of normal mouse mammary stem cells. It was derived from a mammary adenocarcinoma that spontaneously arose in a MMTV-PyMY (mouse mamm...